查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679391

美国伤口清洗市场规模、份额、趋势分析报告：按产品、产品形式、应用、最终用途和细分市场预测，2025-2030 年

U.S. Wound Wash Market Size, Share & Trends Analysis Report By Product (Antiseptic, Saline Solution), By Product Form (Solutions, Sprays, Wipes), By Application (Acute Wounds, Chronic Wounds), By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国伤口清洗市场的成长与趋势

根据Grand View Research, Inc.的最新报告，美国伤口清洗市场规模预计到2030年将达到4.2081亿美元，预测期内的复合年增长率为5.56%。

由于手术和创伤病例的增加以及糖尿病溃疡和压疮等慢性伤口的盛行率不断上升，美国的伤口清洗市场正在经历显着增长。随着抗菌剂、生物膜破坏溶液和自动灌溉系统的进步，传统的伤口清洗方法已经发生了变化，使得创伤护理更加有效和高效。向先进抗菌解决方案的转变是推动伤口清洗市场发展的最重要因素之一。

美国伤口清洗市场的新产品发布和 FDA核准正在透过刺激创新、提高安全标准和改善临床结果来推动伤口清洗和手术清洗的重大进步。 2023 年 6 月，Armis Biopharma 的 VeriCyn 伤口清洗液获得 FDA 的 510(k) 批准，标誌着创伤护理解决方案取得了重要进展。此项核准确保了该产品符合伤口碎片清除的安全性和有效性标准，增强了其可信度和广泛采用性。此次核准也反映了伤口和外科清洗产品的持续技术进步，促进了创新抗菌和生物活性配方的开发。随着对安全有效的伤口清洗解决方案的需求不断增加，此类 FDA核准将有助于推动市场扩张、改善患者治疗效果并鼓励美国伤口清洗市场的进一步创新。

此外，军事部门和工业相关人员透过战略联盟和伙伴关係增加的投资也对美国创伤护理市场产生了重大影响。这些因素共同推动了创新、增强了产品开发、扩大了市场范围并支持了成长。例如，2024年1月，美国授予总部位于明尼苏达州的3M公司一份价值3420万美元的合同，用于开发针对创伤​​、感染疾病和相关癒合过程的医疗解决方案。这些倡议旨在加强军事和民事环境中对爆炸、烧烫伤和枪伤等急性创伤的照护。

美国伤口清洗市场报告重点

  • 根据产品来看，防腐剂部门贡献了最大的收入份额，因为它能有效预防感染，这是创伤护理中一个主要关注点。
  • 根据产品形式，解决方案部分由于其多功能性、易用性以及清洗各种伤口的能力而贡献了最大的收益占有率。
  • 根据应用，急性伤口部分贡献了最大的收入份额。急性伤口更为常见，通常需要立即护理，从而推动了对伤口清洗产品的需求。
  • 根据最终用途，医院占据市场主导地位，占据最大的收入份额。医院是伤口清洗剂的最大消费者。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国伤口清洗市场变数、趋势与范围

  • 市场体系展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国伤口清洗市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章美国伤口清洗市场：按产品分類的估计和趋势分析

  • 细分仪表板
  • 美国伤口清洗市场产品变化分析
  • 2018-2030 年美国伤口清洗产品市场规模及趋势分析（依产品）
  • 防腐剂
    • 优碘
    • 洛赫西定
    • 聚六聚酰胺（PHMB）
    • 其他的
  • 生理食盐水
  • 灌溉解决方案
  • 脉衝清洗系统
    • 一次性的
    • 可重复使用的
    • 半一次性
  • 其他的

第五章美国伤口清洗市场（按产品类型、估计和趋势分析）

  • 细分仪表板
  • 美国伤口清洗市场产品形态变化分析
  • 2018-2030 年美国伤口清洗产品市场规模及趋势分析（依产品类型）
  • 解决方案
  • 喷
  • 擦拭巾
  • 其他的

第六章美国伤口清洗市场：按应用的估计和趋势分析

  • 细分仪表板
  • 美国伤口清洗市场应用趋势分析
  • 2018-2030年美国伤口清洗市场规模及应用趋势分析
  • 急性伤口
    • 外科性创伤与创伤伤口
    • 烧烫伤和撕裂伤
  • 慢性伤口
    • 糖尿病足溃疡
    • 压疮
    • 静脉性腿部溃疡
    • 其他慢性伤口

第七章美国伤口清洗市场：最终用途、估计与趋势分析

  • 细分仪表板
  • 美国伤口清洗市场的最终用途趋势分析
  • 2018-2030 年美国伤口清洗产品市场规模及最终用途趋势分析
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 军事和国防
  • 其他的

第八章竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Atlantis Consumer Healthcare Inc.
    • Medline Industries, LP
    • B. Braun SE
    • Johnson & Johnson Consumer Inc.（Johnson & Johnson）
    • Zimmer Biomet
    • Urgo Medical North America（URGO Group）
    • Coloplast Corp（Coloplast Group）
    • Molnlycke Health Care AB
    • Cardinal Health
    • Armis Biopharma
    • Bravida Medical
    • Irrimax Corporation
    • BD
    • Sanara MedTech Inc.
    • Pure& Clean
    • Innovacyn, Inc.
Product Code: GVR-4-68040-524-8

U.S. Wound Wash Market Growth & Trends:

The U.S. wound wash market size is anticipated to reach USD 420.81 million by 2030 and is anticipated to expand at a CAGR of 5.56% during the forecast period, according to a new report by Grand View Research, Inc. The U.S. wound wash market is experiencing significant growth due to the increasing number of surgical procedures, trauma cases, and the rising prevalence of chronic wounds such as diabetic ulcers and pressure sores. Traditional wound cleansing methods have evolved with advancements in antimicrobial agents, biofilm-disrupting solutions, and automated irrigation systems, making wound care more effective and efficient. The shift toward advanced antimicrobial solutions is one of the most essential factors driving the wound wash market.

New product launches and FDA approvals in the U.S. wound wash market drive significant wound and surgical wash advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In June 2023, VeriCyn Wound Wash from Armis Biopharma obtained 510(k) clearance from the FDA, marking a significant advancement in wound care solutions. This regulatory approval enhances the credibility and adoption of the product, ensuring it meets safety and efficacy standards for wound debris removal. The approval also reflects ongoing technological advancements in wound and surgical washes, promoting the development of innovative, antimicrobial, and bioactive formulations. As demand for safe and effective wound cleansing solutions grows, such FDA approvals drive market expansion, improve patient outcomes, and encourage further innovations in the U.S. wound wash market.

Furthermore, the U.S. wound care market is significantly influenced by increased investments from military sectors and industry players through strategic collaborations and partnerships. These factors collectively drive innovation, enhance product development, and expand market reach, propelling growth. For instance, in January 2024, the U.S. Army has awarded Minnesota's 3M Company a USD 34.2-million contract to develop medical solutions for traumatic wounds, infection, and associated healing processes. These initiatives aim to enhance care for acute trauma cases such as blasts, burns, and gunshot wounds in military and civilian settings.

U.S. Wound Wash Market Report Highlights:

  • Based on product, the antiseptic segment dominate the market with the largest revenue share owing to their effectiveness in preventing infection, a primary concern in wound care.
  • Based on product form, the solutions segment dominate the market with the largest revenue share owing to their versatility, ease of use, and ability to clean a wide range of wounds.
  • Based on application, the acute wound segment dominate the market with the largest revenue share. Acute wounds, being more common and often requiring immediate care, drive the demand for wound wash products.
  • Based on end-use, the hospitals dominated the market with the largest revenue share owing to their high volume of patients and diverse wound care needs. Hospitals are the largest consumers of wound wash products.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Wound Wash Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing number of surgical procedures
      • 3.2.1.2. Rising prevalence of chronic wounds
      • 3.2.1.3. Advancements in wound and surgical washes
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory approvals & compliance costs
      • 3.2.2.2. Adverse events and complications associated with the use of wound wash
  • 3.3. U.S. Wound Wash Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Wash Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Wound Wash Market Product Movement Analysis
  • 4.3. U.S. Wound Wash Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Antiseptic
    • 4.4.1. Antiseptic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Povidone Iodine
      • 4.4.2.1. Povidone Iodine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Chlorhexidine
      • 4.4.3.1. Chlorhexidine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Polyhexanide (PHMB)
      • 4.4.4.1. Polyhexanide (PHMB) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Saline Solution
    • 4.5.1. Saline Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Irrigation Solution
    • 4.6.1. Irrigation Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Pulsed Lavage Systems
    • 4.7.1. Pulsed Lavage Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Disposable
      • 4.7.2.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Reusable
      • 4.7.3.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. Semi Disposable
      • 4.7.4.1. Semi Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Wound Wash Market: Product Form Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Wound Wash Market Product Form Movement Analysis
  • 5.3. U.S. Wound Wash Market Size & Trend Analysis, by Product Form, 2018 to 2030 (USD Million)
  • 5.4. Solutions
    • 5.4.1. Solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Sprays
    • 5.5.1. Sprays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Wipes
    • 5.6.1. Wipes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Wound Wash Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Wound Wash Market Application Movement Analysis
  • 6.3. U.S. Wound Wash Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Acute Wounds
    • 6.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Surgical & Traumatic Wounds
      • 6.4.2.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Burns & Lacerations
      • 6.4.3.1. Burns & Lacerations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Chronic Wounds
    • 6.5.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Diabetic Foot Ulcers
      • 6.5.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Pressure Ulcers
      • 6.5.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Venous Leg Ulcers
      • 6.5.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Other Chronic Wounds
      • 6.5.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Wound Wash Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Wound Wash Market End Use Movement Analysis
  • 7.3. U.S. Wound Wash Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Specialty Clinics
    • 7.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Ambulatory Surgery Centers
    • 7.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Military & Defense
    • 7.7.1. Military & Defense Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Atlantis Consumer Healthcare Inc.
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Medline Industries, LP
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. B. Braun SE
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Johnson & Johnson Consumer Inc. (Johnson & Johnson)
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Zimmer Biomet
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Urgo Medical North America (URGO Group)
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Coloplast Corp (Coloplast Group)
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Molnlycke Health Care AB
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Cardinal Health
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Armis Biopharma
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Service Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Bravida Medical
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Service Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Irrimax Corporation
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Service Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. BD
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Service Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Sanara MedTech Inc.
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Service Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Pure&Clean
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Service Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Innovacyn, Inc.
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Service Benchmarking
      • 8.2.16.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. U.S. Wound Wash Market, By Product, 2018 - 2030 (USD Million)
  • Table 4. U.S. Wound Wash Market, By Product Form, 2018 - 2030 (USD Million)
  • Table 5. U.S. Wound Wash Market, By Application, 2018 - 2030 (USD Million)
  • Table 6. U.S. Wound Wash Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7. Participant's Overview
  • Table 8. Financial Performance
  • Table 9. Product Benchmarking
  • Table 10. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Wound Wash Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Wound Wash Market, for Antiseptic, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. Wound Wash Market, for Povidone Iodine, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Wound Wash Market, for Chlorhexidine, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. Wound Wash Market, for Polyhexanide (PHMB), 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Wound Wash Market, for Saline Solution, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Wound Wash Market, for Irrigation Solution, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. Wound Wash Market, for Pulsed Lavage Systems, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Wound Wash Market, for Disposable, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Wound Wash Market, for Reusable, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Wound Wash Market, for Semi Disposable, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Wound Wash Market, for Solutions, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Wound Wash Market, for Sprays, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. Wound Wash Market, for Wipes, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Wound Wash Market, for Acute Wounds, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Wound Wash Market, for Surgical & Traumatic Wounds, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Wound Wash Market, for Burns & Lacerations, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Wound Wash Market, for Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Wound Wash Market, for Diabetic Foot Ulcers, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Wound Wash Market, for Pressure Ulcers, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Wound Wash Market, for Venous Leg Ulcers, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Wound Wash Market, for Other Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Wound Wash Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Wound Wash Market, for Specialty Clinics, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Wound Wash Market, for Ambulatory Surgery Centers, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Wound Wash Market, for Military & Defense, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)